Page last updated: 2024-08-23

acetylgalactosamine and Hepatitis B, Chronic

acetylgalactosamine has been researched along with Hepatitis B, Chronic in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Dosne, AG; Goeyvaerts, N; Perez-Ruixo, JJ; Sandra, L; T'jollyn, H; Vermeulen, A	1
Buatois, S; Chan, HL; Cheng, W; Das, S; Gane, E; Grippo, JF; Hu, TH; Kazma, R; Kim, DJ; Kim, HJ; Kim, W; Krippendorff, BF; Leerapun, A; Lemenuel-Diot, A; Lim, TH; Lim, YS; Mueller, H; Pavlovic, V; Surujbally, B; Tanwandee, T; Triyatni, M; Wat, C; Yuen, MF; Zhang, Y	1
Chu, Q; Deckert, J; Hadwiger, P; Hamilton, HL; Hegge, JO; Hossbach, M; Jahn-Hofmann, K; John, M; Klein, JJ; Lewis, DL; McLachlan, A; Oropeza, CE; Roehl, I; Rozema, DB; Vornlocher, HP; Wakefield, DH; Wooddell, CI	1

Trials

1 trial(s) available for acetylgalactosamine and Hepatitis B, Chronic

Article	Year
Clinical Study of Single-Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B. Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:4 Topics: Acetylgalactosamine; Adult; Asialoglycoprotein Receptor; Female; Healthy Volunteers; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Oligonucleotides; Oligonucleotides, Antisense; RNA, Viral; Sustained Virologic Response	2021

Article

Year

Clinical Study of Single-Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B.

Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:4

Topics: Acetylgalactosamine; Adult; Asialoglycoprotein Receptor; Female; Healthy Volunteers; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Oligonucleotides; Oligonucleotides, Antisense; RNA, Viral; Sustained Virologic Response

2021

Other Studies

2 other study(ies) available for acetylgalactosamine and Hepatitis B, Chronic

Article	Year
Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated-Hepatitis B Virus-Infected Mice. The Journal of pharmacology and experimental therapeutics, 2022, Volume: 383, Issue:1 Topics: Acetylgalactosamine; Animals; Asialoglycoprotein Receptor; Dependovirus; Hepatitis B virus; Hepatitis B, Chronic; Male; Mice; RNA, Messenger; RNA, Small Interfering	2022
Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Molecular therapy : the journal of the American Society of Gene Therapy, 2013, Volume: 21, Issue:5 Topics: Acetylgalactosamine; Amino Acid Sequence; Animals; Binding Sites; Cholesterol; Drug Delivery Systems; Female; Gene Knockdown Techniques; Genetic Therapy; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Macaca fascicularis; Male; Mice; Peptides; RNA Interference; RNA, Small Interfering; RNA, Viral	2013

Article

Year

Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated-Hepatitis B Virus-Infected Mice.

The Journal of pharmacology and experimental therapeutics, 2022, Volume: 383, Issue:1

Topics: Acetylgalactosamine; Animals; Asialoglycoprotein Receptor; Dependovirus; Hepatitis B virus; Hepatitis B, Chronic; Male; Mice; RNA, Messenger; RNA, Small Interfering

2022

Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection.

Molecular therapy : the journal of the American Society of Gene Therapy, 2013, Volume: 21, Issue:5

Topics: Acetylgalactosamine; Amino Acid Sequence; Animals; Binding Sites; Cholesterol; Drug Delivery Systems; Female; Gene Knockdown Techniques; Genetic Therapy; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Macaca fascicularis; Male; Mice; Peptides; RNA Interference; RNA, Small Interfering; RNA, Viral

2013